email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2644-1373

LOJ Pharmacology & Clinical Research

Research Article(ISSN: 2644-1373)

Safety of Birth Control and Contraception: Pharmaceutical Companies on the Testing Bench

Volume 1 - Issue 4

Kurt Kraetschmer MD, PhD*

  • Author Information Open or Close
    • Department of Pharmacology, Austrian-American Medical Research Institute

    *Corresponding author: Kurt Kraetschmer, Department of Pharmacology, Austrian-American Medical Research Institute

Received:June 27, 2019   Published:July 03, 2019

DOI: 10.32474/LOJPCR.2019.01.000116

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Aim: On the background of reports concerning harm to the health of users of a contraceptive product, the paper aims at emphasizing the manufacturers’ responsibility to warrant safe use of contraceptive pills and devices.

Method: The method consists in an analysis of sources of information commonly used by women and their healthcare providers, ie, “information for use“ provided by manufacturers and statements by renowned agencies, such as WHO, FDA, National Center for Health Research, and CDC. Also, research publications in scholarly journals are critically analysed.

Results: Presently, women do not receive information necessary for the safe use of contraceptive pills and devices -- neither from all pharmaceutical companies nor from healthcare providers.

Conclusion: Comprehensive, complete, and reliable information on all available methods of contraception is difficult to obtain. Pharmaceutical companies should be obliged by law to inform the users of their products in a comprehensible manner about all risks and potential complications without using a confusing, deceptive, or misleading vocabulary.

Materials| Methods| Findings| Discussion| The Manufacturer’s Description of the Implant for Sterilization and INSTRUCTIONS for Use| Deficits in the Information for Use Provided by the Manufacturer| An Implant in Disguise of an Insert| Women in Search of “Safe” Methods of Birth Control and Contraception| Conclusion and Implications| References|

https://www.high-endrolex.com/21